Image For Activity Cover
Minimum Core Data Elements for Evaluation of TAVR: A Scientific Statement by PASSION CV, HVC, and TVT Registry (JACC Interventions April 2022)

Transcatheter aortic valve replacement (TAVR) is standard of care for severe, symptomatic aortic stenosis. Real-world TAVR data collection contributes to benefit/risk, and safety evidence for the U.S. Food and Drug Administration, quality evaluation for the Centers for Medicare and Medicaid Services and hospitals, as well as clinical research and real-world implementation through appropriate use criteria.


JACC: Cardiovascular Interventions Editor-in-Chief

David J. Moliterno, MD, FACC

JACC: Cardiovascular Interventions CME/MOC/ECME Editor

Michael C. McDaniel, MD


Matheus Simonato, MD
Sreekanth Vemulapalli, MD
Mitchell Krucoff, MD

Important Dates

Date of Release: April 4, 2022
Term of Approval/Date of CME/MOC/ECME Expiration: April 3, 2023

Availability: On-Demand
Expires on Apr 03, 2023
Cost: FREE
Credit Offered:
1 CME Credit
1 ABIM-MOC Point
1 ECME Credit
Android App Download IOS App Download Powered By